Rchr
J-GLOBAL ID:201801017624286926   Update date: Oct. 09, 2024

Naoe Yoshinori

Naoe Yoshinori
Affiliation and department:
Homepage URL  (1): https://www.med.nagoya-u.ac.jp/intlexch/cancerimmuno/www/index.html
Research field  (1): Immunology
Papers (48):
  • Patricia Angela Sibal, Shigeru Matsumura, Toru Ichinose, Itzel Bustos-Villalobos, Daishi Morimoto, Ibrahim R Eissa, Mohamed Abdelmoneim, Mona Alhussein Mostafa Aboalela, Nobuaki Mukoyama, Maki Tanaka, et al. STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy. Molecular oncology. 2024. 18. 5. 1259-1277
  • Noriyuki Miyajima, Ibrahim Ragab Eissa, Mohamed Abdelmoneim, Yoshinori Naoe, Toru Ichinose, Shigeru Matsumura, Itzel Bustos-Villalobos, Nobuaki Mukoyama, Daishi Morimoto, Masahiro Shibata, et al. S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model. Nagoya journal of medical science. 2021. 83. 4. 683-696
  • Ibrahim Ragab Eissa, Nobuaki Mukoyama, Mohamed Abdelmoneim, Yoshinori Naoe, Shigeru Matsumura, Itzel Bustos-Villalobos, Toru Ichinose, Noriyuki Miyajima, Daishi Morimoto, Maki Tanaka, et al. Oncolytic herpes simplex virus HF10 (canerpaturev, C-REV) promotes accumulation of CD8+ PD-1- tumor-infiltrating T cells in PD-L1- enriched tumor microenvironment. International journal of cancer. 2021
  • Zhiwen Wu, Toru Ichinose, Yoshinori Naoe, Shigeru Matsumura, Itzel Bustos Villalobos, Ibrahim Ragab Eissa, Suguru Yamada, Noriyuki Miyajima, Daishi Morimoto, Nobuaki Mukoyama, et al. Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth. Molecular therapy oncolytics. 2019. 13. 107-115
  • Kazuhiko Matsuoka, Yukihiro Kohara, Yoshinori Naoe, Atsushi Watanabe, Masako Ito, Kyoji Ikeda, Sunao Takeshita. WAIF1 Is a Cell-Surface CTHRC1 Binding Protein Coupling Bone Resorption and Formation. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2018. 33. 8. 1500-1512
more...
MISC (6):
  • 森本 大士, 直江 吉則, 一ノ瀬 了, Bustos Itzel, 神田 光郎, 丹羽 由紀子, 岩田 直樹, 林 真路, 小林 大介, 田中 千恵, et al. ヒト膵癌異種移植モデルにおけるnab-Paclitaxel(nab-PTX)と腫瘍溶解性単純ヘルペスウイルスHF10との併用療法. 日本外科学会定期学術集会抄録集. 2017. 117回. PS-160
  • Mari Tenno, Yoshinori Naoe, Sawako Muroi, Ichiro Taniuchi. Unique role of Cbf beta 2 variant in Langerhans cell development (P4492). JOURNAL OF IMMUNOLOGY. 2013. 190
  • Shinya Sakaguchi, Matthias Hombauer, Yoshinori Naoe, Ivan Bilic, Alexandra Schebesta, Ichiro Taniuchi, Wilfried ElImeler. Altered CD4/CD8 cell fate decision in the absence of MAZR due to redirected differentiation of MHC class I-restricted thymocytes. JOURNAL OF IMMUNOLOGY. 2009. 182
  • Takeshi Egawa, Robert E. Tillman, Yoshinori Naoe, Ichiro Taniuchi, Dan R. Littman. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells (vol. 204, pg, 1945, 2007). JOURNAL OF EXPERIMENTAL MEDICINE. 2008. 205. 8. 1939-1939
  • A. Kitoh, M. Ono, Y. Naoe, H. Yaguchi, N. Ohkura, I. Kitabayashi, T. Tsukada, T. Nomura, Y. Miyachi, I. Taniuchi, et al. Essential roles of Runx/AML transcription factors for FoxP3(+) regulatory T-cell function. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2008. 128. S165-S165
more...
Professional career (1):
  • 薬学博士 (京都大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page